Scott Grindrod

Asymmetric Synthesis of 2,3-Dihydro-2-arylquinazolin-4-ones: Methodology and Application to a Potent Fluorescent Tubulin Inhibitor with Anticancer Activity

Gary M. Chinigo, Mikell Paige, Scott Grindrod et al. · Journal of Medicinal Chemistry · 2008 · 205 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Dhqz Analogues +13

Allosteric Activation of Protein Phosphatase 2C by <scp>d</scp>-<i>chiro</i>-Inositol−Galactosamine, a Putative Mediator Mimetic of Insulin Action

David L. Brautigan, Milton L. Brown, Scott Grindrod et al. · Biochemistry · 2005 · 49 citations

Glycobiology, Molecular Biology, Allosteric Activation +22

Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6

Shujie Hou, Yong Weon Yi, Hyo Jin Kang et al. · Journal of Medicinal Chemistry · 2014 · 46 citations · Full text

Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor

Yali Kong, Mira Jung, Kan Wang et al. · Molecular Cancer Therapeutics · 2011 · 40 citations · Full text

Histone Modifications, Hdac Inhibitors, Molecular Regulation +22

Meso-Substituted [34]Octaphyrin(1.1.1.0.1.1.1.0) and Corrole Formation in Reactions of a Dipyrromethanedicarbinol with 2,2‘-Bipyrrole

G. Richard Geier, Scott Grindrod · The Journal of Organic Chemistry · 2004 · 40 citations

Medicinal Chemistry, Chemical Engineering, Engineering +14